Abstract: The present invention provides a supporting hook structure, comprising a sleeve, a fixing rod, a first limit unit, a hook and a fixing device. The fixing rod is connected to the side surface of the sleeve. The hook body is connected to one end of the sleeve. The first limit unit is arranged on the side surface of the sleeve and adjacent to the hook body. The first limit unit makes the hook body rotates with the axis direction of the sleeve as a rotation axis. The fixing device is connected to the other end of the sleeve to fix the rotating position of the hook body. Through the above, the hook part enters the proximal thigh from a surgical entrance and the hook part rotates to make the hook part abut against the proximal femur to complete the positioning and fixation of the femur hook structure to the femur.

Abstract: A supported metallocene catalyst includes a carrier and a metallocene component. The carrier includes an inorganic oxide particle and an alkyl aluminoxane material. The inorganic oxide particle includes at least one inorganic oxide compound selected from the group consisting of an oxide of Group 3A and an oxide of Group 4A. The alkyl aluminoxane material includes an alkyl aluminoxane compound and an alkyl aluminum compound that is present in amount ranging from greater than 0.01 wt % to less than 14 wt % base on 100 wt % of the alkyl aluminoxane material. The metallocene component is supported on the carrier, and includes one of a metallocene compound containing a metal from Group 3B, a metallocene compound containing a metal from Group 4B, and a combination thereof. A method for preparing the supported metallocene catalyst and a method for preparing polyolefin using the supported metallocene catalyst are also disclosed.

Abstract: The disclosure provides a power management method. The power management method is applicable to an electronic device. The electronic device is electrically coupled to an adapter, and includes a system and a battery. The adapter has a feed power. The battery has a discharge power. The power management method of the disclosure includes: reading a power value of the battery; determining a state of the system; and discharging power to the system, when the system is in a power-on state and the power value is greater than a charging stopping value, by using the battery, and controlling, according to the discharge power and the feed power, the adapter to selectively supply power to the system. The disclosure further provides an electronic device using the power management method.

Abstract: Disclosed herein is a refined product obtained from a rice hull, which consists essentially of a type II arabinogalactan having a number average molecular weight in the range of 56 to 103 kDa. Also disclosed are a process for producing the refined product and use of the refined product for enhancing the biological activity of innate immune cells, as well as for treating allergy and cancer.

Abstract: Disclosed herein is a refined product obtained from a rice hull, which consists essentially of a type II arabinogalactan having a number average molecular weight in the range of 56 to 103 kDa. Also disclosed are a process for producing the refined product and use of the refined product for enhancing the biological activity of innate immune cells, as well as for treating allergy and cancer.

Abstract: A pharmaceutical composition useful for hepatoprotection is provided. The composition comprises an effective amount of kinsenoside or a pharmaceutically acceptable salt or ester thereof. An aqueous extract of Anoectochilus spp. is also provided. The extract is substantially free of ethyl acetate-philic components.

Abstract: A method for inhibiting the activity of matrix metalloproteinase (MMP), inhibiting the expression of matrix metalloproteinase, inhibiting the phosphorylation of mitogen-activated protein kinase (MAPK), and/or promoting the expression of collagen in a mammal is provided.

Abstract: A vehicle simulation system includes a compiler module, a parser module, a wrapper module, a modeling module, and a simulation module. The compiler module generates object code that is compatible with a first type of operating system based on source code that is executable by a vehicle control module and that is compatible with a second type of operating system. The parser module generates a definitions file and an extensible markup language (XML) file based on the source code and the object code. The wrapper module generates a library file based on the object code and the definitions file. The modeling module generates model-based source code for a virtual model based on the XML file and a user configuration of the virtual model. The simulation module simulates operation of a plant of a vehicle with the virtual model.

Abstract: Provided is a method for inhibiting the activation of macrophages in a subject, comprising administrating to the subject an effective amount of an active component selected from the group consisting of a compound of formula (I), a pharmaceutically acceptable salt of the compound, and a pharmaceutically acceptable ester of the compound, and combinations thereof:

Abstract: An Anoectochilus spp. polysaccharide extract for stimulating the growth of advantageous bacteria, stimulating the release of granulocyte colony-stimulating factor (G-CSF), modulating T helper cell type I (Th1 cell), and/or modulating T helper cell type II (Th2 cell) is provided. The extract comprises an effective amount of a type II arabinogalactan of Anoectochilus spp. Also provided are a method for the preparation of the Anoectochilus spp. polysaccharide extract and the use of the extract.

Abstract: Provided is a method for inhibiting the activation of macrophages in a subject, comprising administrating to the subject an effective amount of an active component selected from the group consisting of a compound of formula (I), a pharmaceutically acceptable salt of the compound, and a pharmaceutically acceptable ester of the compound, and combinations thereof:

Abstract: A method for inhibiting the activity of matrix metalloproteinase (MMP), inhibiting the expression of matrix metalloproteinase, inhibiting the phosphorylation of mitogen-activated protein kinase (MAPK), and/or promoting the expression of collagen in a mammal is provided.

Abstract: A method for inhibiting the activation of macrophages, inhibiting the formation of osteoclasts, inhibiting the function of osteoclasts, and/or activating osteoblasts in a mammal is provided.

Abstract: A vehicle simulation system includes a compiler module, a parser module, a wrapper module, a modeling module, and a simulation module. The compiler module generates object code that is compatible with a first type of operating system based on source code that is executable by a vehicle control module and that is compatible with a second type of operating system. The parser module generates a definitions file and an extensible markup language (XML) file based on the source code and the object code. The wrapper module generates a library file based on the object code and the definitions file. The modeling module generates model-based source code for a virtual model based on the XML file and a user configuration of the virtual model. The simulation module simulates operation of a plant of a vehicle with the virtual model.

Abstract: A pharmaceutical composition useful for hepatoprotection is provided. The composition comprises an effective amount of kinsenoside or a pharmaceutically acceptable salt or ester thereof. An aqueous extract of Anoectochilus spp. is also provided. The extract is substantially free of ethyl acetate-philic components.

Abstract: A method for inhibiting the formation and/or activation of osteoclasts in a mammal comprising administrating an effective amount of a compound of formula (I) or a pharmaceutically acceptable salt or ester thereof to the mammal is provided: Also provided is a method for the preparation of a Flemingia macrophylla extract.

Abstract: An Anoectochilus spp. polysaccharide extract for stimulating the growth of advantageous bacteria, stimulating the release of granulocyte colony-stimulating factor (G-CSF), modulating T helper cell type I (Th1 cell), and/or modulating T helper cell type II (Th2 cell) is provided. The extract comprises an effective amount of a type II arabinogalactan of Anoectochilus spp. Also provided are a method for the preparation of the Anoectochilus spp. polysaccharide extract and the use of the extract.

Abstract: A method for inhibiting the activation of macrophages, inhibiting the formation of osteoclasts, inhibiting the function of osteoclasts, and/or activating osteoblasts in a mammal is provided.

Abstract: A pharmaceutical composition useful for hepatoprotection is provided. The composition comprises an effective amount of kinsenoside or a pharmaceutically acceptable salt or ester thereof. An aqueous extract of Anoectochilus spp. is also provided. The extract is substantially free of ethyl acetate-philic components.

Abstract: A re-closure device for a pop-top can is convenient to use, is plastic or metal and has an inside end, an outside end, a bottom protrusion and two opposite sides. The pop-top can has a top lid, an annular lip around the top lid, an opening defined in the top lid and a pull-tab attached to the top lid by a pivot fastener. The inside end connects to the pivot fastener and engages simultaneously the pull-tab. The outside end has a frame that holds onto the annular lip, an outer lip for removing conveniently the re-closure device and a retaining lip extending from the outer lip to engage the annular lip to hold the re-closure device on the top lid. The bottom protrusion is held in and seals the opening.